Ambev S.A. (NYSE:ABEV) Receives $2.69 Consensus PT from Brokerages

Shares of Ambev S.A. (NYSE:ABEVGet Free Report) have been assigned an average recommendation of “Hold” from the seven research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $2.6933.

ABEV has been the topic of a number of recent analyst reports. Weiss Ratings upgraded shares of Ambev from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, March 5th. Wall Street Zen upgraded shares of Ambev from a “hold” rating to a “buy” rating in a report on Sunday. Barclays raised their price objective on shares of Ambev from $2.50 to $3.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 17th. Finally, Sanford C. Bernstein restated a “market perform” rating and issued a $2.88 target price on shares of Ambev in a research report on Wednesday, November 26th.

Check Out Our Latest Report on Ambev

Ambev Price Performance

Shares of ABEV opened at $2.86 on Monday. The firm has a market capitalization of $44.99 billion, a price-to-earnings ratio of 15.86, a price-to-earnings-growth ratio of 2.05 and a beta of 0.64. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 0.96. Ambev has a one year low of $2.10 and a one year high of $3.24. The stock’s fifty day moving average is $2.92 and its 200-day moving average is $2.57.

Ambev (NYSE:ABEVGet Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. The business had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.28 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. Equities analysts anticipate that Ambev will post 0.18 EPS for the current year.

Institutional Trading of Ambev

Institutional investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC acquired a new position in Ambev during the first quarter worth about $26,000. Millennium Management LLC raised its position in Ambev by 62.5% in the first quarter. Millennium Management LLC now owns 2,399,472 shares of the company’s stock worth $5,591,000 after acquiring an additional 922,566 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Ambev by 13.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 5,000,107 shares of the company’s stock valued at $11,650,000 after acquiring an additional 582,153 shares during the last quarter. Focus Partners Wealth bought a new position in shares of Ambev during the 1st quarter valued at about $33,000. Finally, Acadian Asset Management LLC bought a new position in shares of Ambev during the 1st quarter valued at about $264,000. Institutional investors and hedge funds own 8.13% of the company’s stock.

Ambev Company Profile

(Get Free Report)

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.

Featured Stories

Analyst Recommendations for Ambev (NYSE:ABEV)

Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.